Medicine

Medical physicist Nick Zacharopoulos, chief executive of Aktina Medical, talks with Tami Freeman about developing radiation-oncology technologies and combining industry with academic research. He traces a career that began building radiotherapy components with his father, discusses product development at Aktina, and explains how persistence and a conversation with a colleague led him to a doctorate at McGill University.

Carnegie Mellon researcher and Abridge co-founder Zachary Lipton discusses where machine learning can help healthcare and why clinical work is harder to automate than software development. The conversation examines medical documentation, decision support, drug discovery, open models and model routing, then turns to academic research, doctoral training and the effects of automation on scientific careers. Hosted by Ravid Shwartz Ziv and Allen Roush. Watch the full conversation on the publisher’s YouTube channel.

Vincent Racaniello speaks with Roberto Cattaneo and Kalpana Yadav at the 2026 American Society for Virology meeting about measles persistence in the brain. They discuss selection for highly fusogenic viral variants when usual measles receptors are absent, neuron-to-neuron spread, and the development of subacute sclerosing panencephalitis, a rare, fatal delayed complication of measles infection.

Paul Bieniasz joins Vincent Racaniello, Alan Dove and Kathy Spindler to discuss his laboratory’s research on coronavirus genetic variation. The conversation examines how the NSP15 nuclease cuts viral RNA into short pieces that can be reinserted elsewhere, producing insertion mutations and new furin-cleavage sites at the spike S1/S2 boundary. The episode links the underlying preprint and includes listener correspondence and weekly selections.

Help Danish research institutions recruit faculty and establish independent research groups in life sciences, medicine and other fields relevant to health or sustainability, including data science and AI. Four-year support is capped at DKK 5 million for assistant professors, DKK 8 million for associate professors and DKK 10 million for full or eligible clinical professors. The institution’s appointment authority must apply for an identified candidate. The deadline is 8 October 2026 at 2 p.m. Copenhagen time.

Develop research expertise and independence within an agreed host-led project aligned with Nelson Mandela University research themes. This call covers Council Postdoctoral, Vice-Chancellor’s Postdoctoral and Research Fellowships. First secure an eligible university host and faculty endorsement, then submit the online application, both CVs, host support, two references and qualification documents by 9 October 2026. The application form requires sign-in.

Support for Brazilian business research and innovation using artificial intelligence, aligned with the Nova Indústria Brasil missions and the Brazilian AI plan. Eligible applications include health-industry innovation. A company-linked coordinator submits one project through Plataforma Integrada Carlos Chagas by 9 October 2026, 23:59 Brasília time. Use the required project template and identify the requested fellowship profiles; researchers are selected after award.

Train in pathogen genomic epidemiology and bioinformatics through a PhD registered at Wits in Johannesburg. NICD mentors lead the work, with US co-mentors at Pittsburgh or CDC and part of the training expected in the United States. Apply by 10 October 2026 using the programme’s email instructions. Submit a CV, motivation, two references, MSc certificate and transcript, and South African identification. Opportunities start as soon as possible.

RSNA 2026: At the Center of Care - the Radiological Society of North America's annual meeting at McCormick Place, Chicago, exploring the central role radiologists and imaging scientists play in ensuring better patient care, with technical exhibits Nov 29-Dec 2.

This conference connects Latin American researchers using computation to investigate biological questions. Its programme combines invited lectures, contributed research, tutorials and networking across biomedical omics, microbial communities, comparative and population genomics, molecular sequences and structures, systems biology and networks. It brings together biology, computing, mathematics, statistics and medicine, while introducing scientists new to bioinformatics to tools for analysing biological data. Published keynotes examine AI integration of genomic and phenotypic data for antimicrobial resistance, diagnostics and biomarkers; inclusive genomic studies and biobanks addressing Latin American ancestry and health; network models of non-coding RNA and host-pathogen interactions for drug repurposing and precision medicine; and AI that moves from environmental sensing toward ecological explanation and conservation decisions. Keynote schedule, in Peru Time (PET, UTC−05:00): 11 November, 09:00–10:00 José Arturo Molina Mora (University of Costa Rica) and 16:30–17:30 Andrés Moreno-Estrada (Cinvestav); 12 November, 09:00–10:00 Deisy Morselli Gysi (Federal University of Paraná) and 16:30–17:30 Layla Hirsh Martinez (Pontificia Universidad Católica del Perú); 13 November, 11:00–12:00 Tanya Berger-Wolf (Ohio State University). These are the published keynote sessions; consult the organizer for other sessions. Attend in person at the Universidad de Ingeniería y Tecnología auditorium, Jr. Medrano Silva 165, Barranco, Lima, Peru, or virtually through the conference platform. The auditorium seats 320. Public registration accepts members and nonmembers. Current individual fees are USD 105–255 in person or USD 40–90 virtually, depending on career category and membership. Tutorials cost an additional USD 25 for members or USD 35 for nonmembers; the closing party costs USD 20. In-person fees include breaks and lunch. Both formats include virtual-platform and recorded-session access. Oral presenters are normally expected in person; remote presentation requires an approved waiver for qualifying barriers.

PharmSci 360 connects experimental, computational and clinical evidence across drug discovery, development and delivery. Researchers will examine in-vitro-to-human translation using PBPK, quantitative systems pharmacology and AI; organ-chip and other human-relevant models; biomarkers and reliable bioanalytical assays; and integrating clinical trials with real-world data. Manufacturing sessions connect process understanding, analytical characterization and digital models with quality and scale-up. Formulation sessions address predictive design, advanced materials, targeted delivery and patient usability, alongside career development. Programme participants include Julie L. Gerberding (Foundation for the National Institutes of Health (FNIH)); Stephanie Barrett (Merck & Co., Inc.); Ben Boyd (Monash Institute of Pharmaceutical Sciences); Stephan Schmidt (University of Florida); Douglas Kiehl (Purdue University); Samir Mitragotri (Harvard University); Eric Appel (Stanford University). The American Association of Pharmaceutical Scientists hosts this in-person meeting at the Ernest N. Morial Convention Center, New Orleans, on 25–28 October 2026. The opening plenary is 25 October, 17:00–18:30; principal scientific symposia start at 09:00 on 26–28 October. The closing plenary is 28 October, 16:15–17:30, followed by a reception until 18:30. Times are America/Chicago, CDT (UTC−05:00). Current full-conference fees are US$1,705 for members, US$2,145 for non-members and US$325 for student/postdoc members; one-day passes are available. Registration requires an AAPS portal account. Use the official registration page linked from the event website. Ordinary cancellation refunds are no longer available.